CVRdatabase
Menu

Astellas Pharma A/S

Public limited companyCVR 10888638København SActive

Astellas Pharma A/S is a public limited company, based in København S, active in wholesale of pharmaceutical goods and nursing supplies, founded in 1987. Net profit fell 8% from 2025 to 2026, ending at DKK 5.2m. With 66 employees, the company is about 7 times larger than the industry median. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2026

RevenueDKK 197.9m+3.6% vs. 2025
Net profitDKK 5.2m−8.3% vs. 2025
EquityDKK 20.1m−3.6% vs. 2025
Employees66latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2026 against 2025

  • Gross profit fell 10% (2025 → 2026), to DKK 22m.
  • Revenue rose 4% (2025 → 2026), to DKK 197.9m.
  • Net profit fell 8% (2025 → 2026), to DKK 5.2m.
  • Equity fell 4% (2025 → 2026), to DKK 20.1m.

Employees

  • 7 fewer employees than a year earlier: 66 (08/2026) against 73 (08/2025).

Management and owners, last 24 months

  • New in management: Mark Andree Dekker (board member, 01/12/2025), Mark Andree Dekker (director, 01/12/2025) and Anne Nymand (board member, 01/06/2026) (+3).
  • Stepped down: Karl Håkan Lennart Widen (ceo, 11/03/2025), Malene Abildstrøm (board member, 31/05/2026) and Karl Håkan Lennart Widen (board member, 11/03/2025) (+3).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2026 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60m202120222023202420252026
EquityNet profit
Financial figures for Astellas Pharma A/S
202120222023202420252026Change
Revenue160,457179,933180,837186,855191,027197,863+3.6%
Gross profit24,10226,17523,10120,88724,41122,028−9.8%
Operating profit (EBIT)5,1889,0145,0985,9325,7925,752−0.7%
Profit before tax7,8449,1392,9036,0187,5206,855−8.8%
Net profit5,8656,6892,0814,4705,7055,229−8.3%
Total assets145,455345,591112,042100,770109,956110,985+0.9%
Equity59,43758,22635,30724,69620,81420,071−3.6%
Liabilities85,972287,36576,73576,05789,120––
Cash and cash equivalents6,96012,87813,9019,4096,7335,889−12.5%
Average number of employees12011210397960−100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25m202120222023202420252026
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2026 figures

  • Fewer employees

    The number of employees fell 100% from 96 in 2025 to 0 in 2026.

    How is this calculated?

    The number of employees according to the annual report has fallen by at least 25%, and was at least 10 the year before.

  • Profit for five years in a row

    Net result has been positive in 2022–2026.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Astellas Pharma A/S
Financial yearPeriodPublishedFigures forDocuments
202601/04/2025 – 31/03/202608/07/2026The companyPDF not statedXBRL
202501/04/2024 – 31/03/202530/06/2025The companyPDF not statedXBRL
202401/04/2023 – 31/03/202401/10/2024The companyPDFXBRL
202301/04/2022 – 31/03/202329/09/2023The companyPDFXBRL
202201/04/2021 – 31/03/202207/10/2022The companyPDFXBRL
202101/04/2020 – 31/03/202103/09/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02040608009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 22mNo. 90 of 232
Better than 61% of the companies in the industry
EquityDKK 20.1mNo. 92 of 232
Better than 61% of the companies in the industry
Number of employees66No. 217 of 232
Better than 6% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 3,138of 4,412
Better than 29%
No. 2,192of 4,466
Better than 51%
Same industry and 50–199 employees30 companies in the comparison
No. 28of 30
Better than 7%
No. 27of 30
Better than 10%
Companies that are at least 30 years old10,276 companies in the comparison
No. 2,649of 10,152
Better than 74%
No. 3,398of 10,275
Better than 67%
All companies of type A/S18,025 companies in the comparison
No. 5,521of 17,786
Better than 69%
No. 6,159of 18,024
Better than 66%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Astellas Pharma A/SDKK 22m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Astellas Pharma A/SDKK 5.2m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Astellas Pharma A/SDKK 20.1m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Astellas Pharma A/S66
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Astellas Pharma Europe LTD.100%
Astellas Pharma A/S

Management

5 active registrations

Executive management

Executive management at Astellas Pharma A/S
NameRoleAppointed
Mark Andree DekkerDirector01/12/2025

Board of directors

Board of directors at Astellas Pharma A/S
NameRoleAppointed
Damla Ebru AtilganChair of the board06/10/2022
Mark Andree DekkerBoard member01/12/2025
Anne NymandBoard member01/06/2026
Giuseppe MaduriBoard member01/06/2026
Founders
A/S Pse Nr. 1285, Pehsb ApS, ApS Hvkmd 5 Nr. 555
Former management (42)
Former management at Astellas Pharma A/S
NameRoleAppointedResigned
Ulf Svejgaard PoulsenBoard member01/07/198715/01/1988
Susanne Saul StakemannChair of the board01/07/198715/01/1988
Per Emil Hasselbalch StakemannBoard member01/07/198715/01/1988
Per Emil Hasselbalch StakemannDirector01/07/198715/01/1988
Berend Nico HuismanBoard member01/07/198728/06/1991
Berend Nico HuismanDirector01/07/198728/06/1991
Stead Arthur EllisBoard member01/07/198729/03/2004
Stead Arthur EllisDirector01/07/198729/03/2004
Arnold Johan WesterveldBoard member01/07/198719/09/1989
Andre Louis De HaasBoard member01/07/198720/03/1991
Simon Johannes QuistBoard member01/07/198720/03/1991
Arend PaasmanBoard member01/07/198701/03/1998
Masakatsu InoueBoard member01/07/198703/03/1994
Shigekazu TakahashiBoard member01/07/198709/02/2001
Henricus Johannes HuibertsBoard member01/07/198710/08/1998
Philippe Andre Pierre BalleroBoard member01/03/199830/09/2001
Douwe Wybe WitteveenBoard member10/08/199829/12/1999
Johannes Adrianus de HeusBoard member30/08/200027/12/2002
Yasuo IshiiChair of the board09/02/200129/03/2004
Pedro MøllebroBoard member13/12/200205/07/2016
Wilhelmus Jacques Josephus KockelkorenChair of the board13/12/200224/08/2005
Herman Levinus Pierre BreepoelBoard member29/03/200424/08/2005
Herman Levinus Pierre BreepoelDirector29/03/200409/05/2005
Mats Stefan PerssonCEO09/05/200506/07/2016
Gillian Kay MitchellBoard member24/08/200506/07/2016
Hiroshi NogawaBoard member24/08/200512/07/2007
Mats Stefan PerssonBoard member24/08/200506/07/2016
Seiji KinoshitaBoard member12/07/200717/03/2010
Nicolaas Jacobus StanderChair of the board17/03/201006/07/2016
Niels Walther-RasmussenBoard member06/07/201614/12/2021
Pedro MøllebroChair of the board06/07/201630/06/2020
Jan Anders Martin NordénBoard member06/07/201601/04/2019
Jan Anders Martin NordénCEO06/07/201601/04/2019
Pia Terésa LindkvistBoard member01/04/201901/07/2021
Pia Terésa LindkvistCEO01/04/201907/06/2021
Yagnaram SantharamChair of the board30/06/202006/10/2022
Karl Håkan Lennart WidenCEO07/06/202111/03/2025
Malene AbildstrømBoard member01/07/202131/05/2026
Karl Håkan Lennart WidenBoard member01/07/202111/03/2025
Rowena BorensteinBoard member14/12/202131/05/2026
Morten AuscherBoard member11/03/202501/12/2025
Morten AuscherCEO11/03/202501/12/2025

Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening, af et medlem af bestyrelsen og en direktør eller af to direktører eller af den samlede bestyrelse.

Address and production units

1 active production units

Arne Jacobsens Allé 15
2300 København S

København Municipality · Postcode 2300

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
ASTELLAS PHARMA A/SArne Jacobsens Allé 15, 2300 København S661000148274

Purpose

Selskabets formål er: at etablere, at erhverve og at finansiere, at deltage i og udføre management i andre virksomheder, at handle med produkter indenfor fødevare-, sundheds- og miljøområdet, at udvikle og/eller at producere sådanne produkter, alt i videste forstand, at erhverve og afhænde immaterialrettigheder og at udøve enhver handling, som er knyttet til eller er en konsekvens af det foranstående i videst muligt omfang.

The purpose is quoted from the register in Danish.

Changes year by year

107 registered events
20265 changesaccounts 1 · management 4
  • Annual report for 2026 published
  • Giuseppe Maduri appointed board member
  • Anne Nymand appointed board member
  • Rowena Borenstein stepped down as board member
  • Malene Abildstrøm stepped down as board member
20259 changesmanagement 8 · accounts 1
  • Mark Andree Dekker appointed board member
  • Mark Andree Dekker appointed director
  • Morten Auscher stepped down as board member
  • Morten Auscher stepped down as ceo
  • Annual report for 2025 published
  • Morten Auscher appointed board member
  • Morten Auscher appointed ceo
  • Karl Håkan Lennart Widen stepped down as board member
  • Karl Håkan Lennart Widen stepped down as ceo
20241 changeaccounts 1
  • Annual report for 2024 published
20231 changeaccounts 1
  • Annual report for 2023 published
20223 changesaccounts 1 · management 2
  • Annual report for 2022 published
  • Damla Ebru Atilgan appointed chair of the board
  • Yagnaram Santharam stepped down as chair of the board
20219 changesmanagement 7 · accounts 1 · address 1
  • Rowena Borenstein appointed board member
  • Niels Walther-Rasmussen stepped down as board member
  • Annual report for 2021 published
  • Moved to Arne Jacobsens Allé 15, 2300 København S
  • Karl Håkan Lennart Widen appointed board member
  • Malene Abildstrøm appointed board member
  • Pia Terésa Lindkvist stepped down as board member
  • Karl Håkan Lennart Widen appointed ceo
  • Pia Terésa Lindkvist stepped down as ceo
20202 changesmanagement 2
  • Yagnaram Santharam appointed chair of the board
  • Pedro Møllebro stepped down as chair of the board
20195 changesaddress 1 · management 4
  • Moved to Kajakvej 2, 2770 Kastrup
  • Pia Terésa Lindkvist appointed ceo
  • Pia Terésa Lindkvist appointed board member
  • Jan Anders Martin Nordén stepped down as ceo
  • Jan Anders Martin Nordén stepped down as board member
20169 changesmanagement 9
  • Pedro Møllebro appointed chair of the board
  • Jan Anders Martin Nordén appointed ceo
  • Jan Anders Martin Nordén appointed board member
  • Niels Walther-Rasmussen appointed board member
  • Nicolaas Jacobus Stander stepped down as chair of the board
  • Mats Stefan Persson stepped down as board member
  • Gillian Kay Mitchell stepped down as board member
  • Mats Stefan Persson stepped down as ceo
  • Pedro Møllebro stepped down as board member
20151 changeownership 1
  • Astellas Pharma Europe LTD. registered as owner (100%)
20111 changeaddress 1
  • Moved to Kajakvej 2, 2770 Kastrup
20102 changesmanagement 2
  • Nicolaas Jacobus Stander appointed chair of the board
  • Seiji Kinoshita stepped down as board member
20072 changesmanagement 2
  • Seiji Kinoshita appointed board member
  • Hiroshi Nogawa stepped down as board member
20058 changesmanagement 7 · name 1
  • Hiroshi Nogawa appointed board member
  • Mats Stefan Persson appointed board member
  • Gillian Kay Mitchell appointed board member
  • Herman Levinus Pierre Breepoel stepped down as board member
  • Wilhelmus Jacques Josephus Kockelkoren stepped down as chair of the board
  • Name changed from YAMANOUCHI PHARMA A/S to ASTELLAS PHARMA A/S
  • Mats Stefan Persson appointed ceo
  • Herman Levinus Pierre Breepoel stepped down as director
20045 changesmanagement 5
  • Herman Levinus Pierre Breepoel appointed director
  • Herman Levinus Pierre Breepoel appointed board member
  • Yasuo Ishii stepped down as chair of the board
  • Stead Arthur Ellis stepped down as director
  • Stead Arthur Ellis stepped down as board member
20024 changesmanagement 3 · address 1
  • Johannes Adrianus de Heus stepped down as board member
  • Pedro Møllebro appointed board member
  • Wilhelmus Jacques Josephus Kockelkoren appointed chair of the board
  • Moved to Naverland 4, 2600 Glostrup
20013 changesmanagement 3
  • Philippe Andre Pierre Ballero stepped down as board member
  • Yasuo Ishii appointed chair of the board
  • Shigekazu Takahashi stepped down as board member
20002 changesmanagement 1 · capital 1
  • Johannes Adrianus de Heus appointed board member
  • Share capital changed from 500,000 DKK to 600,000 DKK
19991 changemanagement 1
  • Douwe Wybe Witteveen stepped down as board member
19984 changesmanagement 4
  • Douwe Wybe Witteveen appointed board member
  • Henricus Johannes Huiberts stepped down as board member
  • Philippe Andre Pierre Ballero appointed board member
  • Arend Paasman stepped down as board member
19961 changecapital 1
  • Share capital changed from 300,000 DKK to 500,000 DKK
19942 changesmanagement 1 · name 1
  • Masakatsu Inoue stepped down as board member
  • Name changed from BROCADES PHARMA A/S to YAMANOUCHI PHARMA A/S
19915 changesname 1 · management 4
  • Name changed from GIST-BROCADES PHARMACEUTICALS A/S to BROCADES PHARMA A/S
  • Berend Nico Huisman stepped down as director
  • Berend Nico Huisman stepped down as board member
  • Simon Johannes Quist stepped down as board member
  • Andre Louis De Haas stepped down as board member
19891 changemanagement 1
  • Arnold Johan Westerveld stepped down as board member
19885 changesname 1 · management 4
  • Name changed from A/S PSE 13 NR. 1079 to GIST-BROCADES PHARMACEUTICALS A/S
  • Per Emil Hasselbalch Stakemann stepped down as director
  • Per Emil Hasselbalch Stakemann stepped down as board member
  • Ulf Svejgaard Poulsen stepped down as board member
  • Susanne Saul Stakemann stepped down as chair of the board
198716 changesfounded 1 · management 15
  • Registered as A/S PSE 13 NR. 1079
  • Stead Arthur Ellis appointed director
  • Stead Arthur Ellis appointed board member
  • Berend Nico Huisman appointed director
  • Berend Nico Huisman appointed board member
  • Per Emil Hasselbalch Stakemann appointed director
  • Per Emil Hasselbalch Stakemann appointed board member
  • Ulf Svejgaard Poulsen appointed board member
  • Susanne Saul Stakemann appointed chair of the board
  • Henricus Johannes Huiberts appointed board member
  • Shigekazu Takahashi appointed board member
  • Masakatsu Inoue appointed board member
  • Arend Paasman appointed board member
  • Simon Johannes Quist appointed board member
  • Andre Louis De Haas appointed board member
  • Arnold Johan Westerveld appointed board member

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction